Back to 
Franklin Templeton Inc.
Franklin Templeton Inc.
RCKT
27 quarters
Position history for Franklin Templeton Inc.'s holdings in Rocket Pharmaceuticals, Inc.
Yes. Franklin Templeton holds 10,166 shares of RCKT (Rocket Pharmaceuticals), worth $34,768, as of its Q2 2026 13F filing. It reduced the position by 929 shares (-8.4%) from Q1 2026. Franklin Templeton has held RCKT since Q4 2025, across 3 quarterly 13F filings.
Current Value
$34,768
Current Shares
10,166
Total Value Change
-$5.3M
Total Shares Change
-450,108
Quarter-by-Quarter History
Other major holders of RCKT: RTW Investments, LP